Exane Derivatives’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Exane Derivatives’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,259	Closed	-$4.41K	–	762
2018 Q3	$4.41K	Sell	1,259 -24,247	-95%	-$87.4K	﹤0.01%	467
2018 Q2	$92.2K	Hold	25,506	–	–	0.02%	343
2018 Q1	$101K	Buy	+25,506	New	+$119K	0.02%	300

Exane Derivatives's KERX Position: Q4 2018 in Review

Exane Derivatives sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 1,259 shares — an estimated $4.41K sold.

Exane Derivatives first reported a position in KERX in Q1 2018 and held it in 3 quarters. The position peaked at $101K in Q1 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Exane Derivatives reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Exane Derivatives sold 1,259 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $4.41K.
Exane Derivatives first reported a position in Keryx Biopharmaceuticals Inc in Q1 2018 and held it in 3 quarters.
Exane Derivatives's Keryx Biopharmaceuticals Inc position peaked at $101K in Q1 2018.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.